Aruba Networks, GM, Juniper, Rosetta Stone: U.S. Equity Preview

percent or more over the next year, Barron���s reported, citing Brian Marshall, analyst at Gleacher & Co. Merck & Co. (MRK US) rose 0.7 percent to $37.35. The second-largest U.S. drugmaker won U.S. approval for the first hepatitis C drug in almost a...